Log In
BCIQ
Print this Print this
 

Ortho-ACI

  Manage Alerts
Collapse Summary General Information
Company Orthocell Ltd.
DescriptionAutologous chondrocyte implantation
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentMarketed
Standard IndicationCartilage repair
Indication DetailsTreat symptomatic defects of the articulating cartilage of the joints, predominately the knee and ankle
Regulatory Designation
PartnerGrandhope Biotech Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1.6M

$1.6M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/10/2013

$1.6M

$1.6M

0

Get a free BioCentury trial today